The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions

Details for Australian Patent Application No. 2004211931 (hide)

Owner Bioresponse, L.L.C.

Inventors Zeligs, Michael A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004211931

PCT Pub. Number WO2004/071425

Priority 60/445,888 06.02.03 US; 60/445,916 06.02.03 US

Filing date 6 February 2004

Wipo publication date 26 August 2004

International Classifications

A61K 033/24 Medicinal preparations containing inorganic active ingredients - Heavy metals

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/071425 Priority application(s): WO2004/071425

13 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004211936-10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

2004211920-Solid phase sequencing